Abstract
Rare cases of acute promyelocytic leukemia (APL) are associated with a t(11;17) translocation and a PLZF-RARalpha fusion transcript. Because of molecular specificities of the fusion protein, ATRA efficiency is often reduced in these cases. We present herein the case of an 83-year old patient which has been successfully treated by ATRA and Daunorubicin. The described quantitative RT-PCR method allowed successful monitoring and confirmation of the molecular response.
Vol. 91 No. 12_Suppl (2006): December, 2006 : Articles
Published By
Ferrata Storti Foundation, Pavia, Italy
Statistics from Altmetric.com